{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:33Z","timestamp":1788484413408,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218755","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:23:48Z","timestamp":1784676228000},"page":"218755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual Beclin 1 post-translational reprogramming by BCR-ABL and HDAC6 inhibition disables autophagic flux and overcomes CML resistance"],"prefix":"10.1016","volume":"658","author":[{"given":"Ji Yeon","family":"Paik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Boyer-Orlikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-8176","authenticated-orcid":false,"given":"Claudia","family":"Cerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-9538","authenticated-orcid":false,"given":"Michael","family":"Schnekenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2026.218755_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2026.218755_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jmgm.2019.03.018","article-title":"Molecular dynamics investigation on the Asciminib resistance mechanism of I502L and V468F mutations in BCR-ABL","volume":"89","author":"Zhan","year":"2019","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.canlet.2026.218755_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"14","key":"10.1016\/j.canlet.2026.218755_bib4","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3390\/cancers14143300","article-title":"Mechanisms of resistance and implications for treatment strategies in chronic myeloid leukaemia","volume":"14","author":"Poudel","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.canlet.2026.218755_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41375-018-0252-4","article-title":"Targeting quiescent leukemic stem cells using second generation autophagy inhibitors","volume":"33","author":"Baquero","year":"2019","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.canlet.2026.218755_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12032-025-02895-y","article-title":"Potential therapeutic targets in chronic myeloid leukemia","volume":"42","author":"Bansal","year":"2025","journal-title":"Med. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2026.218755_bib7","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1182\/blood-2013-07-516807","article-title":"The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem\/progenitor cells","volume":"123","author":"Rothe","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2026.218755_bib8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3324\/haematol.2018.212027","article-title":"Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia","volume":"105","author":"Yu","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.canlet.2026.218755_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218755_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/cancers12020318","article-title":"HDAC6-an emerging target against chronic myeloid leukemia?","volume":"12","author":"Losson","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.canlet.2026.218755_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2013.09.026","article-title":"Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases","volume":"343","author":"Seidel","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218755_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105058","article-title":"The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia","volume":"160","author":"Losson","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218755_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119652","article-title":"Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia","volume":"201","author":"Paik","year":"2026","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.canlet.2026.218755_bib14","first-page":"2738","article-title":"A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia","volume":"141","author":"Krishnan","year":"2023","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2026.218755_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218755_bib16","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1038\/ncomms8215","article-title":"Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth","volume":"6","author":"Sun","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2026.218755_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.canlet.2026.218755_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218755_bib19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-D","article-title":"Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line","volume":"17","author":"Law","year":"1993","journal-title":"Leuk. Res."},{"issue":"11","key":"10.1016\/j.canlet.2026.218755_bib20","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:43:51Z","timestamp":1788482631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S0304383526005197"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218755","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual Beclin 1 post-translational reprogramming by BCR-ABL and HDAC6 inhibition disables autophagic flux and overcomes CML resistance","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218755"}}